Literature DB >> 34302012

Preexisting heart failure with reduced ejection fraction attenuates renal fibrosis after ischemia reperfusion via sympathetic activation.

Ryo Matsuura1, Tetsushi Yamashita1, Naoki Hayase2, Yoshifumi Hamasaki1, Eisei Noiri1, Genri Numata3, Eiki Takimoto3, Masaomi Nangaku1, Kent Doi4.   

Abstract

Although chronic heart failure is clinically associated with acute kidney injury (AKI), the precise mechanism that connects kidney and heart remains unknown. Here, we elucidate the effect of pre-existing heart failure with reduced ejection fraction (HFrEF) on kidney via sympathetic activity, using the combining models of transverse aortic constriction (TAC) and unilateral renal ischemia reperfusion (IR). The evaluation of acute (24 h) and chronic (2 weeks) phases of renal injury following IR 8 weeks after TAC in C57BL/6 mice revealed that the development of renal fibrosis in chronic phase was significantly attenuated in TAC mice, but not in non-TAC mice, whereas no impact of pre-existing heart failure was observed in acute phase of renal IR. Expression of transforming growth factor-β, monocyte chemoattractant protein-1, and macrophage infiltration were significantly reduced in TAC mice. Lastly, to investigate the effect of sympathetic nerve activity, we performed renal sympathetic denervation two days prior to renal IR, which abrogated attenuation of renal fibrosis in TAC mice. Collectively, we demonstrate the protective effect of pre-existing HFrEF on long-term renal ischemic injury. Renal sympathetic nerve may contribute to this protection; however, further studies are needed to fully clarify the comprehensive mechanisms associated with attenuated renal fibrosis and pre-existing HFrEF.
© 2021. The Author(s).

Entities:  

Year:  2021        PMID: 34302012     DOI: 10.1038/s41598-021-94617-3

Source DB:  PubMed          Journal:  Sci Rep        ISSN: 2045-2322            Impact factor:   4.379


  34 in total

1.  Regulation of Mitochondrial Dynamics by Dynamin-Related Protein-1 in Acute Cardiorenal Syndrome.

Authors:  Maki Sumida; Kent Doi; Emi Ogasawara; Tetsushi Yamashita; Yoshifumi Hamasaki; Taro Kariya; Eiki Takimoto; Naoki Yahagi; Masaomi Nangaku; Eisei Noiri
Journal:  J Am Soc Nephrol       Date:  2015-02-02       Impact factor: 10.121

2.  Risk Factors for Recurrent Acute Kidney Injury in a Large Population-Based Cohort.

Authors:  Kathleen D Liu; Jingrong Yang; Thida C Tan; David V Glidden; Sijie Zheng; Leonid Pravoverov; Chi-Yuan Hsu; Alan S Go
Journal:  Am J Kidney Dis       Date:  2018-10-25       Impact factor: 8.860

3.  Cardiorenal Syndrome: Classification, Pathophysiology, Diagnosis, and Treatment Strategies: A Scientific Statement From the American Heart Association.

Authors:  Janani Rangaswami; Vivek Bhalla; John E A Blair; Tara I Chang; Salvatore Costa; Krista L Lentine; Edgar V Lerma; Kenechukwu Mezue; Mark Molitch; Wilfried Mullens; Claudio Ronco; W H Wilson Tang; Peter A McCullough
Journal:  Circulation       Date:  2019-04-16       Impact factor: 29.690

4.  Impact of Renal Impairment on Beta-Blocker Efficacy in Patients With Heart Failure.

Authors:  Dipak Kotecha; Simrat K Gill; Marcus D Flather; Jane Holmes; Milton Packer; Giuseppe Rosano; Michael Böhm; John J V McMurray; John Wikstrand; Stefan D Anker; Dirk J van Veldhuisen; Luis Manzano; Thomas G von Lueder; Alan S Rigby; Bert Andersson; John Kjekshus; Hans Wedel; Frank Ruschitzka; John G F Cleland; Kevin Damman; Josep Redon; Andrew J S Coats
Journal:  J Am Coll Cardiol       Date:  2019-12-10       Impact factor: 24.094

5.  Pivotal role of cardiomyocyte TGF-β signaling in the murine pathological response to sustained pressure overload.

Authors:  Norimichi Koitabashi; Thomas Danner; Ari L Zaiman; Yigal M Pinto; Janelle Rowell; Joseph Mankowski; Dou Zhang; Taishi Nakamura; Eiki Takimoto; David A Kass
Journal:  J Clin Invest       Date:  2011-05-02       Impact factor: 14.808

Review 6.  Renal impairment, worsening renal function, and outcome in patients with heart failure: an updated meta-analysis.

Authors:  Kevin Damman; Mattia A E Valente; Adriaan A Voors; Christopher M O'Connor; Dirk J van Veldhuisen; Hans L Hillege
Journal:  Eur Heart J       Date:  2013-10-27       Impact factor: 29.983

Review 7.  Cardiorenal syndrome--current understanding and future perspectives.

Authors:  Branko Braam; Jaap A Joles; Amir H Danishwar; Carlo A Gaillard
Journal:  Nat Rev Nephrol       Date:  2013-11-19       Impact factor: 28.314

Review 8.  Cardiorenal syndrome.

Authors:  Claudio Ronco; Mikko Haapio; Andrew A House; Nagesh Anavekar; Rinaldo Bellomo
Journal:  J Am Coll Cardiol       Date:  2008-11-04       Impact factor: 24.094

9.  Proenkephalin, Renal Dysfunction, and Prognosis in Patients With Acute Heart Failure: A GREAT Network Study.

Authors:  Leong L Ng; Iain B Squire; Donald J L Jones; Thong Huy Cao; Daniel C S Chan; Jatinderpal K Sandhu; Paulene A Quinn; Joan E Davies; Joachim Struck; Oliver Hartmann; Andreas Bergmann; Alexandre Mebazaa; Etienne Gayat; Mattia Arrigo; Eiichi Akiyama; Zaid Sabti; Jens Lohrmann; Raphael Twerenbold; Thomas Herrmann; Carmela Schumacher; Nikola Kozhuharov; Christian Mueller
Journal:  J Am Coll Cardiol       Date:  2017-01-03       Impact factor: 24.094

10.  Predicting Renal Recovery After Dialysis-Requiring Acute Kidney Injury.

Authors:  Benjamin J Lee; Chi-Yuan Hsu; Rishi Parikh; Charles E McCulloch; Thida C Tan; Kathleen D Liu; Raymond K Hsu; Leonid Pravoverov; Sijie Zheng; Alan S Go
Journal:  Kidney Int Rep       Date:  2019-01-28
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.